TARSUS PHARMACEUTICALS, INC. (TARS) /
The debt of TARSUS PHARMACEUTICALS, INC. over the past 8 years
Chart TARSUS PHARMACEUTICALS, INC.: liquid cash, total debt, net cash, fiscal 2018–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, TARSUS PHARMACEUTICALS, INC. had liquid cash of $417.27M and total debt of $72.44M: net cash of $344.83M. It had more liquid cash than debt at all 7 year-ends shown. Total debt was highest at the end of fiscal 2025 ($72.44M) and lowest at the end of fiscal 2019 ($0).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $417.27M* | $72.44M | $344.83M |
| 2024ended Dec 31, 2024 | $291.38M* | $71.84M | $219.53M |
| 2023ended Dec 31, 2023 | $227.44M* | $29.82M | $197.62M |
| 2022ended Dec 31, 2022 | $217.03M* | $19.43M | $197.59M |
| 2021ended Dec 31, 2021 | $171.81M* | $0 | $171.81M |
| 2020ended Dec 31, 2020 | $168.13M* | $0 | $168.13M |
| 2019ended Dec 31, 2019 | $58M | $0 | $58M |
| 2018 | — | — | — |
Fiscal years as TARSUS PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on TARSUS PHARMACEUTICALS, INC.
- The revenue of TARSUS PHARMACEUTICALS, INC.
- The profitability of TARSUS PHARMACEUTICALS, INC.
- The cash flow of TARSUS PHARMACEUTICALS, INC.
- All of TARSUS PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- NTCTNETSCOUT SYSTEMS INC
- PRVAPrivia Health Group, Inc.
- BWINThe Baldwin Insurance Group, Inc.
- WSCWillscot Holdings Corporation
- EXTRExtreme Networks, Inc.
Not investment advice. This page shows what TARSUS PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.